FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia ...
Biomea Fusion has escaped from the full clinical hold imposed by the FDA. | Biomea Fusion has escaped from the full clinical hold imposed by the FDA. After reviewing the data, the regulator has ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by ...
CRAWFORDVILLE, Fla. — Hurricane Helene weakened to a tropical storm over Georgia with maximum sustained winds of 70 mph (110 ...
Drinking too much coffee has a reputation of being harmful, but a new study says having three cups a day can lower the risk of developing more than one cardiometabolic disease.
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” ...
The combined entity will have a stronger financial profile, enhanced R&D capabilities, and a streamlined supply chain, allowing it to serve global pharmaceutical clients more effectively ...